#USA #financial results #Wilmington #DuPont #Q1 2026

DuPont Reports Solid Results for Q1 2026

WILMINGTON, Del., May 5, 2026 — DuPont (NYSE: DD) recently announced its first quarter financial results for 2026, highlighting a strong start to the year, exceeding initial guidance and advancing expectations for the full year. With net sales of $1.7 billion reflecting a 4% increase compared to the same quarter in the previous year, the company reported a promising trend in its operational performance.

Key Highlights

• - Net Sales: $1.681 billion, a 4% increase, buoyed by a 2% organic sales growth.
• - GAAP Income from Continuing Operations rose to $150 million, an astonishing 88% growth.
• - Operating EBITDA reached $414 million, a 15% year-over-year increase.
• - Cash flow from operating activities stood at $232 million, emphasizing strong liquidity management.
• - DuPont's Board has initiated a $275 million accelerated share repurchase program, showing continued commitment to returning value to shareholders.

Strategic Focus and Operational Excellence

DuPont's CEO, Lori Koch, attributed the company’s performance to disciplined commercial strategies and operational excellence, remaining targeted on customer satisfaction and organic growth. "We have maintained our focus on value creation while aligning our resources to drive consistent performance for our shareholders," Koch stated. The emphasis appears to be on enhancing margins, as indicated by a 24.6% operating EBITDA margin, which improved by 230 basis points over the previous year.

Financial Guidance for Full Year 2026

Looking forward, DuPont has raised its full-year guidance based on the current momentum. The revised projection estimates net sales of approximately $7.155 billion to $7.215 billion, anticipating organic growth of about 4% and taking into account pricing adjustments due to rising input costs. The operating EBITDA for the entire year is projected in the range of $1.730 billion to $1.760 billion. Adjusted earnings per share (EPS) is now expected to be around $2.35 to $2.40.

Segment Performance Overview

DuPont’s two primary segments, Healthcare & Water Technologies and Diversified Industrials, showed contrasting growth trajectories in the first quarter:
1. Healthcare & Water Technologies: Achieved a 6% increase in net sales at $806 million with 3% organic sales growth despite some disruption.
2. Diversified Industrials: Posted a more modest 3% growth in net sales, totaling $875 million, with organic sales remaining relatively flat.

Conclusion

As DuPont navigates a dynamic market landscape, the combination of solid financial results and proactive management of operational efficiencies positions the company favorably. The commitment to customer-centric engagements and sustainable financial practices is expected to resonate positively with investors and stakeholders alike. The upcoming conference call with investors will delve further into these results and discuss future strategies.

For more detailed insights, visit www.dupont.com for the latest news and information regarding DuPont's financial performance and strategy moving forward.